Does cCR5Delta32 mutation influence the susceptibility to HCV infection , severity of liver disease and response to therapy in patients with chronic hepatitis C?
CCR5Delta32 mutation does not have a role in disease susceptibility, severity or response to therapy in patients with chronic hepatitis C infection.
  With this in vitro study, ZA mediated defective bone mineralization by directly disrupting osteoblast/osteoprogenitor cellular activities at several levels, that is, cell proliferation, osteoblast differentiation, and osteoblast function of both pre-osteoblastic cells and MSC.